Dr. Satya Pal Kataria

Dr. Satya Pal Kataria is Vice-Chairman of Medical Oncology at Medanta - The Medicity in Gurugram, bringing over 28 years of distinguished clinical experience in cancer care. A graduate of JIPMER, Pondicherry (MBBS and MD in General Medicine) and AIIMS, New Delhi (DM in Medical Oncology), he has honed his expertise through decades of dedicated practice at premier Indian institutions. His career trajectory reflects an exceptional commitment to oncological excellence, including a prolonged tenure at VMMC – Safdarjung Hospital, New Delhi, where he rose to head the Department of Medical Oncology.

Dr. Kataria specializes in comprehensive cancer management across multiple modalities. His clinical focus encompasses adjuvant and neoadjuvant chemotherapy, advanced immunotherapy including immune checkpoint inhibitor therapy, molecular targeted therapy, and hormone-based treatments for breast and prostate cancers. He is particularly skilled in biomarker-guided therapeutic selection, allowing him to tailor treatment plans to each patient's individual tumour biology. His expertise extends to palliative chemotherapy, ensuring compassionate care for patients with advanced disease. Over three decades, he has managed thousands of cancer patients with a reputation for rigorous clinical judgment and outcome-oriented practice.

Dr. Kataria welcomes international patients from across the Gulf region, Africa, and South Asia, and has considerable experience managing complex oncology cases in a multicultural setting. He is fluent in English and Hindi, facilitating clear communication with diverse patient populations. Medanta's international patient services team assists with documentation review, pre-treatment planning, and remote consultations via video, making access seamless for those traveling from abroad.

Medanta - The Medicity stands as one of India's leading tertiary care institutions, recognised for its world-class oncology infrastructure. The hospital boasts state-of-the-art chemotherapy suites, advanced diagnostic imaging (PET-CT, MRI), molecular pathology laboratories for biomarker testing, and dedicated inpatient oncology wards with 24/7 critical care support. Located in Gurugram's healthcare corridor, Medanta combines academic rigour with patient-centric care, making it a preferred destination for international cancer patients seeking evidence-based, personalised treatment.

International patients choosing Dr. Kataria benefit from his decades of clinical leadership, access to cutting-edge cancer therapeutics, and Medanta's comprehensive support infrastructure. His 32+ publications in reputed Indian and international journals reflect his ongoing commitment to advancing medical oncology through research and scholarly contribution. Whether seeking a second opinion, initial diagnosis, or complex treatment planning, patients receive care grounded in the latest oncological evidence and delivered with the institutional rigour of a premier Indian medical centre.